Syed Hasan to Pneumonia, Viral
This is a "connection" page, showing publications Syed Hasan has written about Pneumonia, Viral.
Connection Strength
0.420
-
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020 Nov; 50(4):814-821.
Score: 0.029
-
Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease. Rheumatol Int. 2020 12; 40(12):2117-2118.
Score: 0.029
-
The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic. Headache. 2020 10; 60(9):2085-2086.
Score: 0.029
-
Use of Azithromycin in COVID-19: A Cautionary Tale. Clin Drug Investig. 2020 10; 40(10):989-990.
Score: 0.029
-
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020 11; 14(11):1149-1163.
Score: 0.029
-
The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19. Obesity (Silver Spring). 2020 11; 28(11):2035.
Score: 0.029
-
Meta-analysis of Effect of Statins in Patients with COVID-19. Am J Cardiol. 2020 11 01; 134:153-155.
Score: 0.029
-
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide. Am J Cardiovasc Drugs. 2020 Aug; 20(4):301-309.
Score: 0.028
-
Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. Expert Rev Cardiovasc Ther. 2020 Aug; 18(8):475-485.
Score: 0.028
-
Role of frailty in COVID-19 patients. Intensive Care Med. 2020 10; 46(10):1956-1957.
Score: 0.028
-
Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury. J Am Soc Nephrol. 2020 08; 31(8):1917-1918.
Score: 0.028
-
Use of low-molecular-weight heparin in COVID-19 patients. J Vasc Surg Venous Lymphat Disord. 2020 09; 8(5):900-901.
Score: 0.028
-
Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med. 2020 Aug - Sep; 170:106045.
Score: 0.028
-
Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection. 2020 10; 48(5):805-806.
Score: 0.028
-
Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J Drug Target. 2020 Aug-Sep; 28(7-8):683-699.
Score: 0.007
-
Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020 Jun; 20(3):217-221.
Score: 0.007
-
Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" Nutrients 2020, 12(4), 988. Nutrients. 2020 Jun 01; 12(6).
Score: 0.007